 |
 |
NADH FAQ's Q. What is NADH? A. NADH is the abbreviation for the reduced form of nicotinamide-adenine-dinucleotide. This reduced form contains high en= ergy hydrogen (the H in NADH) that provides energy to the cell. NADH occur= s in all living cells and plays a central role in the energy production of= the cells(1). The more energy a cell needs, the more NADH it needs. For e= xample, muscle cells and brain cells contain about 50 micrograms NADH per gra= m tissue, heart cells 90 micrograms, red blood cells 4 micrograms(2). I= n other words, if you supply NADH to the body, it acts as an energy supplemen= t, which provides the organism with additional energy.=20 NADH occurs naturally in the muscle tissue of many animals, such as f= ish, poultry and cattle that are part of our diet (3).=20 Q. What does NADH do in the body? A. NADH is the first and most energetic component in the central ener= gy producing mechanism in our cells(4). Thus it plays a crucial role in supplying our cells with energy.=20 In addition NADH supplies the energy for the production of important compounds in our cells. NADH increases the production of adrenaline a= nd dopamine, particularly in the brain(5, 6) It improves aspects of brai= n and central nervous system function which are related to the activity of dopamine and adrenaline.=20 Q. How was NADH discovered? A. NADH was discovered in 1934 by Kaplan, an American scientist who f= ound that it plays an essential role in the energy production of cells(7).= =20 Q. Who should take NADH? A. Anyone that that wants to support the function of the central nerv= ous system and the energy production in all cells.=20 Q. Who is Georg Birkmayer? A. Professor Georg Birkmayer, MD, Ph.D., is the director of a clinica= l laboratory in Vienna, Austria as well as a world renowned biochemical researcher. He is associated with the University of Vienna and is a v= isiting professor at the University of Beijing, China. He is the general secr= etary of the International Academy of Tumor Marker Oncology. In addition to= being a practicing physician, he is the author of more than 100 scientific = articles.=20 References: 1. Lehninger, A.L. (1970): Biochemistry, Worth Publisher Inc. 1970.= =20 2. Klingenberg M. (1960): Zur Bedeutung der freien Nucleotide. 11.Moo= sbacher Kolloquium Springer Verlag p. 82-114=20 3. Sauberlich H.E. (1987): Nutritional Aspects of Pyridine Nucleotide= s, in Dolphin D, Poulson R., Avramovic O. (editors): Pyridine Nucleotide Co= enzymes (Part B), John Wiley & Sons, Inc. 1987, p. 599-626=20 4. Alberts B, et al (1983): Molecular Biology of the Cell, Garland Publishing, 1983, p. 491-495.=20 5. Vrecko K., Birkmayer JGD and Krainz J. (1993): Stimulation of dopa= mine biosynthesis in cultured PC12 phaeochromocytoma cells by the coenzyme nicotinamide adenine dinucleotide (NADH), J. Neur. Trans. 5:147-156= =20 6. Gardier M. (1994) Study Report to Labor Birkmayer, Department Pharmacology, University Paris Sud.=20 7. Kaplan N.O. (1960) in Boyer PD, Lardy H. and Myrbaeck K.: The Enzy= mes Vol. 3, Ac Press New York p. 156-172=20 Colloidal NaDH, Order Form=20 Home Page=20 ---------------------------------------------------------------------= --- Copyright =A91996 by Chronic Wellness International=99=20 Last Updated 11/03/96=20